PKC-ε is upstream and PKC-α is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 5 56-5, 2004, Pages

  Hassouna, Ashraf ^a   Matata, Bashir M ^a   Galiñanes, Manuel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cardioprotection; Protein kinase C isoforms

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; BISTRATENE A; CALPHOSTIN C; CHELERYTHRINE; DIAZOXIDE; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C ALPHA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; ROTTLERIN; RUBOXISTAURIN; STAUROSPORINE; ENZYME INHIBITOR; MEMBRANE PROTEIN; MITOCHONDRIAL K(ATP) CHANNEL; PRKCA PROTEIN, HUMAN; PRKCE PROTEIN, HUMAN; PROTEIN KINASE C;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE INJURY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; HEART ATRIUM; HEART INFARCTION PREVENTION; IN VITRO STUDY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HEART ATRIA; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MEMBRANE PROTEINS; MITOCHONDRIA, HEART; MYOCARDIUM; PHOSPHORYLATION; POTASSIUM CHANNELS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-EPSILON; SIGNAL TRANSDUCTION;

EID: 7444244876     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00144.2004     Document Type: Article

References (52)

1. Saines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, and Ping P. Protein kinase C-ε interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92: 873-880, 2003.
2. ATP channels in rat mitochondria. J Physiol 547: 893-902, 2003.
3. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
4. Frey MR, Leontieva O, Watters DJ, and Black JD. Stimulation of protein kinase C-dependent and -independent signaling pathways by bistratene A in intestinal epithelial cells. Biochem Pharmacol 61: 1093-1100, 2001.
5. Fryer RM, Hsu AK, Wang Y, Henry M, Eells J, and Gross GJ. PKC-δ inhibition does not block preconditioning-induced preservation in mitochondrial ATP synthesis and infarct size reduction in rats. Basic Res Cardiol 97: 47-54, 2002.
6. Fryer RM, Wang Y, Hsu AK, and Gross GJ. Essential activation of PKC-δ a in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280: H1346-H1353, 2001.
7. + channel in cardiac function and cardioprotection. Biochim Biophys Acta 1606: 1-21, 2003.
8. + channels. Possible mechanism of cardioprotection. Circ Res 81: 1072-1082, 1997.
9. ATP channel as a receptor for potassium channel openers. J Biol Chem 271: 8796-8799, 1996.
10. ATP channels as effectors of human myocardial preconditioning. Cardiovasc Res 45: 934-940, 2000.
11. Ghosh S, Standen NB, and Galiñanes M. Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection. Cardiovasc Res 45: 339-350, 2000.
12. Ghosh S, Standen NB, and Galiñanes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 37: 711-718, 2001.
13. Gray MO, Karliner JS, and Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 272: 30945-30951, 1997.
14. Gross GJ and Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70: 223-233, 1992.
15. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, and Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98, 1994.
16. ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 542: 735-741, 2002.
17. ATP channels, PKC and p38 MAPK? Circulation, Suppl 106: 11-245, 2002.
18. Hassouna A, Matata BM, Loubani M, Fowler A, Standen N, and Galiñanes M. Failure to precondition the diabetics' myocardium correlates with incomplete depolarization of mitochondrial membrane potential (Abstract). Mol Biol Cell, Suppl 14: 227a, 2003.
19. ATP channels. Mol Pharmacol 55: 1000-1005, 1999.
20. Inagaki K, Hahn HS, Dorn GW, and Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and ε-protein kinase C activator. Circulation 108: 869-875, 2003.
21. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH III, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winneroski LL, and Faul MM. (S)-13-[(dimethylamino)methyl]-10,11,14,15- tetrahydro-4,9:16,21-dimetheno-1H,13H-dibenzo[e,k]pyrrolo[3,4h][1,4,13] oxadiazacyclohexadecene-1,3(2H)-dione (LY-333531) and related analogues: isozyme selective inhibitors of protein kinase C-β. J Med Chem 39: 2664-2671, 1996.
22. Johnson JA, Gray MO, Chen CH, and Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271: 24962-24966, 1996.
23. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, and Zaugg M. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery, a double-blinded, placebo-controlled, multicenter study. Anesthesiology 98: 1315-1327, 2003.
24. Kitakaze M, Funaya H, Minamino T, Node K, Sato H, Ueda Y, Okuyama Y, Kuzuya T, Hori M, and Yoshida K. Role of protein kinase C-α in activation of ecto-5′-nucleotidase in the preconditioned canine myocardium. Biochem Biophys Res Commun 239: 171-175, 1997.
25. Li Y and Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol Heart Circ Physiol 268: H426-H431, 1995.
26. Liu GS, Cohen MV, Mochly-Rosen D, and Downey JM. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31: 1937-1948, 1999.
27. ATP channels are upstream and p38MAPK is downstream of PKC. BMC Physiol 2: 10, 2002.
28. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, and Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go-6976. J Biol Chem 268: 9194-9197, 1993.
29. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, and Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 76: 73-81, 1995.
30. 1 receptor activation. J Am Coll Cardiol 35: 238-245, 2000.
31. Newton AC. Protein kinase C: structure, function and regulation. J Biol Chem 270: 28495-28498, 1995.
32. ATP channel occurs down-stream of PKC-ε activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol 283: H440-H447, 2002.
33. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 87: 460-466, 2000.
34. + channels by protein kinase C. Circ Res 83: 110-114, 1998.
35. Saurin AT, Pennington DJ, Raat NJ, Latchman DS, Owen MJ, and Marber MS. Targeted disruption of the protein kinase C-ε gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res 55: 672-680, 2002.
36. Singh H, Hudman D, Lawrence CL, Rainbow RD, Lodwick D, and Norman RI. Distribution of Kir6.0 and SUR2 ATP-sensitive potassium channel subunits in isolated ventricular myocytes. J Mol Cell Cardiol 35: 445-459, 2003.
37. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 77: 1030-1035, 1995.
38. Speechly-Dick ME, Mocanu MM, and Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 75: 586-590, 1994.
39. Suzuki M, Saito T, Sato T, Tamagawa M, Miki T, Seino S, and Nakaya H. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice. Circulation 107: 682-685, 2003.
40. Takai Y, Kishimoto A, Inoue M, and Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 252: 7603-7609, 1977.
41. Vahlhaus C, Schulz R, Post H, Onallah R, and Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 19: 407-414, 1996.
42. Vanden Hoek T, Becker LB, Shao ZH, Li CQ, and Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 86: 541-548, 2000.
43. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, and Boyd MR. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 51: 2515-2520, 1991.
44. Vogt AM, Htun P, Arras M, Podzuweit T, Schaper W. Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res Cardiol 91: 389-400, 1996.
45. Walker DM, Walker JM, Pugsley WB, Pattison CW, and Yellon DM. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 27: 1349-1357, 1995.
46. ATP channels by diazoxide. Circulation 104: 85-90, 2001.
47. Watters D, Garrone B, Coomer J, Johnson WE, Brown G, and Parsons P. Stimulation of melanogenesis in a human melanoma cell line by bistratene A. Biochem Pharmacol 55: 1691-1699, 1998.
48. Wilkinson SE, Parker PJ, and Nixon JS. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294: 335-337, 1993.
49. Yao Z, McPherson BC, Liu H, Shao Z, Li C, Qin Y, Vanden Hoek TL, Becker LB, and Schumacker PT. Signal transduction of flumazenil-induced preconditioning in myocytes. Am J Physiol Heart Circ Physiol 280: H1249-H1255, 2001.
50. Yoshida K, Kawamura S, Mizukami Y, and Kitakaze M. Implication of protein kinase C-α, -δ, and -ε isoforms in ischemic preconditioning in perfused rat hearts. J Biochem (Tokyo) 122: 506-511, 1997.
51. Ytrehus K, Liu Y, and Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol Heart Circ Physiol 266: H1145-H1152, 1994.
52. Zhang JG, Ghosh S, Ockleford CD, and Galiñanes M. Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischaemia and reperfusion in man. Clin Sci (Lond) 99: 443-453, 2000.